Boston Sci Pays J&J $600M To Settle Guidant Merger Suit
Boston Scientific Corp. announced Tuesday it would pay Johnson & Johnson $600 million to settle claims that acquisition target Guidant Corp. breached a contract by scuttling a proposed $21.5 billion merger...To view the full article, register now.
Already a subscriber? Click here to view full article